GLP-1 drugs , or glucagon-like peptide-1 compounds, represent a substantial innovation in how we treat diabetes mellitus . These new therapies work by mimicking the body’s inherent GLP-1 process, which https://nikolasdeek647104.fare-blog.com/42361950/glp-1-a-significant-approach-in-blood-sugar-treatment